FIELD: medicine; chemical and pharmaceutical industry.
SUBSTANCE: invention relates to peroral suspension containing non-dihydrated azytromicina, accipient stabilizing conversion of azytromicina, and aqueous carrier. Also a method of inhibiting conversion of non-dihydrated azytromicina in the peroral suspension has been proposed by mixing a quantity of accipient reducing the surface tension with aqueous carrier and non-dihydrated azytromicina to produce the suspension where the quantity of accipient reducing the surface tension reduced tension in a volume of water equal to the certain volume of aqueous carrier to less than 50 dine/cm (5·10-2 N/m). Besides, a method inhibiting conversion of non-dihydrated azytromicina in the peroral suspension has been proposed, where the peroral suspension contains no conversion accentuator by mixing the viscosity agent with the aqueous carrier and non-dihydrated azytromicina to make the peroral suspension with viscosity of approximately 3 cP (3 mPa·s) or more. A method has been proposed of treating bacterial and protozoal infections in patients by administering peroral suspension.
EFFECT: method inhibits conversion of a form of non-dihydrated azytromicina in peroral suspension.
12 cl, 5 ex, 14 tbl
Title | Year | Author | Number |
---|---|---|---|
DRY GRANULATED AZITHROMICINE COMPOSITIONS | 2003 |
|
RU2283092C2 |
METHODS FOR AZITROMICINE WET GRANULATION | 2002 |
|
RU2283651C2 |
DIRECT PRESSABLE AZITHROMICINE-CONTAINING FORMULATIONS | 2002 |
|
RU2277914C2 |
DISPERSIBLE PREPARATION OF ANTIINFLAMMATION AGENT | 2004 |
|
RU2319508C2 |
CRYSTALLINE AZITHROMYCIN L-MALATE MONOHYDRATE AND PHARMACEUTICAL COMPOSITION INCLUDING IT | 2006 |
|
RU2348644C1 |
METHOD FOR PHARMACEUTICAL MULTIPARTICULATES PRODUCTION | 2004 |
|
RU2331410C2 |
ONDANSETRON-CONTAINING COMPOSITIONS FOR ORAL ADMINISTRATION | 1995 |
|
RU2145853C1 |
COMPOSITIONS OF TETRAHYDROBIOPTERINE AND METHODS OF ITS QUANTITATIVE ASSESSMENT | 2008 |
|
RU2486899C2 |
COMBINED VORICONASOL AND ANTIMYCOTIC INHIBITOR CYP2C19 | 2005 |
|
RU2345769C2 |
PHARMACEUTICAL PREPARATION | 2017 |
|
RU2760681C2 |
Authors
Dates
2008-05-27—Published
2004-05-12—Filed